InvestorsHub Logo
Followers 742
Posts 76940
Boards Moderated 0
Alias Born 01/01/2012

Re: None

Monday, 03/06/2017 10:41:18 AM

Monday, March 06, 2017 10:41:18 AM

Post# of 203922
This seems pretty unusual - in March 2015 there was a OWCP press release:

March 11, 2015 /PRNewswire/ --

OWC Pharmaceutical Research Corp.'s (OTCQB: OWCP) wholly owned subsidiary One World Cannabis Ltd. ("the Company"), signed a collaboration agreement with Sheba Academic Medical Center, the largest hospital in Israel and in the Middle East.

Within the framework of a new collaboration agreement, the company will initiate a study to explore the effect of several combinations of cannabidiol (CBD) and tetrahydrocannabinol (THC) on multiple myeloma, starting with a basic science on multiple myeloma cells.

Dr. Merav Leiba, Head of Multiple Myeloma outpatient clinic and Multiple Myeloma research lab at Sheba Academic Medical Center's hematology institute, will lead the research.

I looked at the research published by Leiba and didn't find any that was Cannabis based.

I guess we need to investigate the OWCP press releases much more closely.

IG

"Are you gonna pull those pistols or whistle Dixie?"